High Expression of Lymphocyte-Activation Gene 3 (LAG3) in Chronic Lymphocytic Leukemia Cells Is Associated with Unmutated Immunoglobulin Variable Heavy Chain Region (IGHV) Gene and Reduced Treatment-Free Survival

Autor: Jitka Kabáthová, Jana Kotašková, Jitka Malčíková, Michael Doubek, Jiri Mayer, Boris Tichy, Šárka Pospíšilová, Hana Skuhrová Francová, Martin Trbušek, Yvona Brychtová
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Adult
Male
Chronic lymphocytic leukemia
Genes
Immunoglobulin Heavy Chain

Immunoglobulin Variable Region
Pathology and Forensic Medicine
03 medical and health sciences
0302 clinical medicine
immune system diseases
Antigens
CD

hemic and lymphatic diseases
Gene expression
medicine
Humans
030304 developmental biology
Aged
Oligonucleotide Array Sequence Analysis
Aged
80 and over

0303 health sciences
ZAP-70 Protein-Tyrosine Kinase
biology
Microarray analysis techniques
Reverse Transcriptase Polymerase Chain Reaction
Middle Aged
medicine.disease
Leukemia
Lymphocytic
Chronic
B-Cell

Lymphocyte Activation Gene 3 Protein
3. Good health
Reverse transcription polymerase chain reaction
Survival Rate
Leukemia
Lipoprotein Lipase
030220 oncology & carcinogenesis
Monoclonal
Immunology
Mutation
biology.protein
Cancer research
Molecular Medicine
Female
Antibody
IGHV@
Regular Articles
Popis: Chronic lymphocytic leukemia (CLL) is characterized by a monoclonal expansion of mature B-lymphocytes. Mutational status of the immunoglobulin variable heavy chain region (IGHV) gene stratifies CLL patients into two prognostic groups. We performed microarray analysis of CLL cells using the Agilent platform to detect the most important gene expression differences regarding IGHV status in CLL cells. We analyzed a cohort of 118 CLL patients with different IGHV mutational status and completely characterized all described prognostic markers using expression microarrays and quantitative real-time RT-PCR (reverse transcription PCR). We detected lymphocyte-activation gene 3 (LAG3) as a novel prognostic marker: LAG3 high expression in CLL cells correlates with unmutated IGHV (P < 0.0001) and reduced treatment-free survival (P = 0.0087). Furthermore, quantitative real-time RT-PCR analysis identified a gene-set (LAG3, LPL, ZAP70) whose overexpression is assigned to unmutated IGHV with 90% specificity (P < 0.0001). Moreover, high expression of tested gene-set and unmutated IGHV equally correlated with reduced treatment-free survival (P = 7.7 * 10−11 vs. P = 1.8 * 10−11). Our results suggest that IGHV status can be precisely assessed using the expression analysis of LAG3, LPL, and ZAP70 genes. Expression data of tested markers provides a similar statistical concordance with treatment-free survival as that of the IGHV status itself. Our findings contribute to the elucidation of CLL pathogenesis and provide novel prognostic markers for possible application in routine diagnostics.
Databáze: OpenAIRE